151 related articles for article (PubMed ID: 9990594)
1. Appropriate use of the implantable cardioverter defibrillator: a Canadian perspective. Canadian Working Group on Cardiac Pacing.
Yee R; Connolly SJ; Gillis AM
Pacing Clin Electrophysiol; 1999 Jan; 22(1 Pt 1):1-4. PubMed ID: 9990594
[No Abstract] [Full Text] [Related]
2. Antiarrhythmic drugs or implantable cardioverter defibrillators in heart failure: the "poor heart".
Böcker D; Breithardt G
Am J Cardiol; 1999 Mar; 83(5B):83D-87D. PubMed ID: 10089846
[TBL] [Abstract][Full Text] [Related]
3. Secondary prevention of sudden death: the Dutch Study, the Antiarrhythmics Versus Implantable Defibrillator Trial, the Cardiac Arrest Study Hamburg, and the Canadian Implantable Defibrillator Study.
Cappato R
Am J Cardiol; 1999 Mar; 83(5B):68D-73D. PubMed ID: 10089843
[TBL] [Abstract][Full Text] [Related]
4. Long-term comparison of the implantable cardioverter defibrillator versus amiodarone: eleven-year follow-up of a subset of patients in the Canadian Implantable Defibrillator Study (CIDS).
Bokhari F; Newman D; Greene M; Korley V; Mangat I; Dorian P
Circulation; 2004 Jul; 110(2):112-6. PubMed ID: 15238454
[TBL] [Abstract][Full Text] [Related]
5. [Canadian Implantable Defibrillator Study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone].
Della Bella P
Ital Heart J Suppl; 2000 Aug; 1(8):1070-1. PubMed ID: 10993020
[No Abstract] [Full Text] [Related]
6. Effect of risk stratification on cost-effectiveness of the implantable cardioverter defibrillator.
Owens DK; Sanders GD; Heidenreich PA; McDonald KM; Hlatky MA
Am Heart J; 2002 Sep; 144(3):440-8. PubMed ID: 12228780
[TBL] [Abstract][Full Text] [Related]
7. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias.
Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators
N Engl J Med; 1997 Nov; 337(22):1576-83. PubMed ID: 9411221
[TBL] [Abstract][Full Text] [Related]
8. Effect of clinical risk stratification on cost-effectiveness of the implantable cardioverter-defibrillator: the Canadian implantable defibrillator study.
Sheldon R; O'Brien BJ; Blackhouse G; Goeree R; Mitchell B; Klein G; Roberts RS; Gent M; Connolly SJ
Circulation; 2001 Oct; 104(14):1622-6. PubMed ID: 11581139
[TBL] [Abstract][Full Text] [Related]
9. Food for afterthought: reflections from 2 implantable cardioverter defibrillator trials.
Rahimtoola SH
Arch Intern Med; 2004 Sep; 164(17):1835-9. PubMed ID: 15451756
[No Abstract] [Full Text] [Related]
10. Impact of the implantable cardioverter-defibrillator on rehospitalizations.
Valenti R; Schlåpfer J; Fromer M; Fischer A; Kappenberger L
Eur Heart J; 1996 Oct; 17(10):1565-71. PubMed ID: 8909915
[TBL] [Abstract][Full Text] [Related]
11. AICD automatic cardioverter defibrillator clinical update: 14 years experience in over 34,000 patients.
Nisam S; Kaye SA; Mower MM; Hull M
Pacing Clin Electrophysiol; 1995 Jan; 18(1 Pt 2):142-7. PubMed ID: 7724388
[No Abstract] [Full Text] [Related]
12. Multicenter experience with a pectoral unipolar implantable cardioverter-defibrillator. Active Can Investigators.
Bardy GH; Yee R; Jung W
J Am Coll Cardiol; 1996 Aug; 28(2):400-10. PubMed ID: 8800117
[TBL] [Abstract][Full Text] [Related]
13. Ventricular arrhythmias, electrophysiologic studies, and devices.
Dhala A; Sra J; Blanck Z; Deshpande S; Jazayeri MR; Akhtar M
Cardiol Clin; 1999 Feb; 17(1):189-95, x. PubMed ID: 10093773
[TBL] [Abstract][Full Text] [Related]
14. Learning more about indications for implantable cardioverter-defibrillators.
Myerburg RJ; Castellanos A
J Am Coll Cardiol; 1999 Oct; 34(4):1096-8. PubMed ID: 10520796
[No Abstract] [Full Text] [Related]
15. Long term management of the survivor of ventricular fibrillation or sustained ventricular tachycardia.
Connolly SJ; Krahn A; Klein G
Can J Cardiol; 2000 Jun; 16 Suppl C():20C-2C. PubMed ID: 10887273
[No Abstract] [Full Text] [Related]
16. Implantable cardioverter-defibrillator: present and future indications.
Block M; Scheld H; Breithardt G
Arch Mal Coeur Vaiss; 1996 Feb; 89 Spec No 1():141-7. PubMed ID: 8734176
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness and cost-effectiveness of implantable cardioverter defibrillators in the treatment of ventricular arrhythmias among medicare beneficiaries.
Weiss JP; Saynina O; McDonald KM; McClellan MB; Hlatky MA
Am J Med; 2002 May; 112(7):519-27. PubMed ID: 12015242
[TBL] [Abstract][Full Text] [Related]
18. Antiarrhythmic drugs versus implantable defibrillators: the need for a randomized controlled study.
Greene HL
Am Heart J; 1994 Apr; 127(4 Pt 2):1171-8. PubMed ID: 8160597
[TBL] [Abstract][Full Text] [Related]
19. Implantable cardioverter-defibrillators: not the ultimate gold standard for gauging therapy of VT/fibrillation.
Singh BN
Am J Cardiol; 1994 Jun; 73(16):1211-3. PubMed ID: 8203341
[No Abstract] [Full Text] [Related]
20. Implantable cardioverter defibrillators in the United States: understanding the benefits and limitations of implantable cardioverter defibrillator therapy based on clinical trial results.
Gottlieb C; Callans DJ; Marchlinski F
Pacing Clin Electrophysiol; 1998 Nov; 21(11 Pt 1):2016-20. PubMed ID: 9826851
[No Abstract] [Full Text] [Related]
[Next] [New Search]
